A middle-aged woman sustained serious heart valve injury (i.e.
primary pulmonary hypertension) from taking a prescribed diet drug
Redux, which contains Fen/Phen. Our firm maintained joint responsibility with an experienced drug injury
firm who settled the case.
$2.5 Million Settlement
A wife and mother of two children died of a cerebral hemorrhage
after taking an over the counter diet drug diet drug containing
Ephedra. The deceased’s husband contacted our firm for help.
Our firm maintained joint responsibility with an experienced product liability attorney who settled
the case.
$900,000 Settlement
We were co-counsel in a case involving a dietary supplement with
PPA. The client suffered a stroke and had a brain bleed that required
two surgeries. Our firm maintained joint responsibility with an experienced product liability attorney
who settled the case.
$ 750,000 Settlement
A teenager committed suicide after taking an anti-depressant drug
for several weeks. The young boy’s life was cut short just
one week before his birthday. Our firm maintained joint responsibility with an experienced product liability
attorney who settled the case.
$1.25 Million Settlement
Our client was the mother of a one year old child who was born with a complex cardiovascular condition. The child was diagnosed with arterial septal defect, ventricular septal defect and congestive heart failure, all conditions caused by the mother's use of Paxil during the first trimester of her pregnancy. Our firm maintained joint responsibility with an experienced drug injury firm who settled the case.
$800,000 Settlement
When Baycol was removed from the market in 2001, we were contacted by many Rhode Islanders who were injured by this medication. Our firm maintained joint responsibility with an experienced attorney in pharmaceutical litigation, who was successful in negotiating a multi-million dollar settlement for several clients.
$2 Million in total Settlements
Due to taking the drug zyprexa, a number of our clients developed type 2 diabetes as a side effect. Our firm maintained joint responsibility with a pharmaceutical litigation law firm, who was successful in negotiating a multi-million dollar settlement for our clients.
$3.8 Million in total
Settlements
A Connecticut man was diagnosed with Type II diabetes after using the medication, Zyprexa. Our firm maintained joint responsibility with an experienced attorney in pharmaceutical litigation, and the case was settled out of court.
$500,000 Settlement
Byetta (exenatide) has been linked to life-threatening side effects including pancreatitis and kidney failure. Amylin Pharmaceuticals, Inc. manufactures Byetta and markets the diabetes drug with Ely Lilly and Co. Byetta was released onto the market and approved by the FDA in April 2005.
Byetta is an injectable prescription drug. Its purpose is to improve the control of glucose (blood sugar) in adults with type 2 diabetes. Byetta has also helped some patients lose weight. However, the primary purpose of Byetta is to regulate blood sugar.
On November 2, 2009, the FDA issued an alert to healthcare professionals that there were changes made to the warning label for Byetta. The change includes information on reports of kidney problems, such as renal failure and renal insufficiency. See link:
http://www.fda.gov/Drugs/DrugSafety/Byetta
The FDA had 78 patients using Byetta who were experiencing altered kidney function. Of the 78 cases, 62 patients suffered acute renal failure, which is a sudden loss of the kidneys. The remaining 16 patients experienced renal insufficiency, which is when the kidneys ability to remove waste from the body is lessened.
On August 18, 2008 the FDA said it planned to strengthen the warnings about life-threatening pancreas problems linked to the type 2 diabetes drug Byetta. This action followed after six Byetta users were hospitalized. Those patients had hemorrhagic pancreatitis or necrotizing pancreatitis. Byetta treatment was stopped. Of the six patients hospitalized, two died.
In October 2007, the FDA noted 30 reports of acute pancreatitis, which is sudden inflammation of the pancreas, in Byetta users. None of those patients had hemorrhagic pancreatitis (inflammation of the pancreas with bleeding) or necrotizing pancreatitis (in which the inflamed pancreas destroys itself). However, 5 of those patients also suffered from kidney failure.
PLEASE SPEAK WITH YOUR DOCTOR BEFORE DISCONTINUING THE USE OF BYETTA OR ANY OTHER PRESCRIPTION DRUGS.
If you believe that you or a loved one has suffered as a result of taking Byetta, you may want to speak with a personal injury attorney, today, regarding your potential lawsuit. An injury lawyer familiar with new developments in the investigation of Byetta may be able to help you make important personal and legal decisions.
Please contact the law offices of d'Oliveira & Associates at 1-800-992-6878 or fill out a contact form for a free legal consultation.